A fixed-dose combination antimalarial medicine used for the treatment of uncomplicated Plasmodium falciparum malaria. Artemisinin provides rapid parasite clearance, while piperaquine offers a long-acting effect to eliminate remaining parasites and reduce the risk of recurrence. It is commonly used in areas with multidrug-resistant malaria and should be taken under medical supervision.